Biohaven Ltd.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

BHVN

organization

SIC: 2834

SEC Insider

$192.8M

354 transactions

Summary

Biohaven Ltd. (BHVN) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $188.2MSales: $460K13 insiders

Date	Insider	Type	Value
2026-01-05	Coric Vlad(Chief Executive Officer)	F	$74K
2026-01-05	Gentile Kimberly(SVP, Clinical Operations)	F	$19K
2026-04-28	CHILDS JOHN W	A	$0
2026-04-28	GREGORY JULIA P	A	$0
2026-04-28	HUGIN ROBERT J	A	$0
2026-04-28	Bailey Gregory	A	$0
2026-04-28	Heffernan Michael Thomas	A	$0
2026-04-28	Mehta Kishan	A	$0
2026-04-28	Antonijevic Irina	A	$0
2026-03-17	Mehta Kishan	G	$0
2026-03-17	Mehta Kishan	G	$0
2026-02-27	Gentile Kimberly(SVP, Clinical Operations)	A	$0
2026-02-27	Coric Vlad(Chief Executive Officer)	A	$0
2026-02-27	Car Bruce(Chief Scientific Officer)	A	$0
2026-02-27	Clark George C.(VP, Chief Accounting Officer)	A	$0
2026-02-27	Buten Matthew(Chief Financial Officer)	A	$0
2026-01-05	Gentile Kimberly(SVP, Clinical Operations)	M	$0
2026-01-05	Gentile Kimberly(SVP, Clinical Operations)	M	$0
2026-01-05	Coric Vlad(Chief Executive Officer)	M	$0
2026-01-05	Coric Vlad(Chief Executive Officer)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Biohaven Ltd. — Contributions, Lobbying & Contracts | Poliscope